These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


169 related items for PubMed ID: 1698429

  • 1. The acute effect of the synthetic prostacyclin analogue iloprost in primary pulmonary hypertension.
    Scott JP, Higenbottam T, Wallwork J.
    Br J Clin Pract; 1990 Jun; 44(6):231-4. PubMed ID: 1698429
    [Abstract] [Full Text] [Related]

  • 2. [Inhalation of a prostacyclin analog (iloprost) in primary and secondary pulmonary hypertension].
    Andreassen AK, Madsen S, Kjekshus J, Simonsen S.
    Tidsskr Nor Laegeforen; 2001 Apr 20; 121(10):1220-3. PubMed ID: 11402748
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of adenosine versus iloprost by acute vasodilator test in patients of pulmonary arterial hypertension complicated with connective tissue diseases].
    Tian Z, Chen TB, Fang Q, Zeng XF, Liu YT, Li MT, Jiang XC, Gao P, Cheng KA, Wang Q.
    Zhonghua Yi Xue Za Zhi; 2009 Aug 11; 89(30):2099-102. PubMed ID: 20058611
    [Abstract] [Full Text] [Related]

  • 4. Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation.
    Opitz CF, Wensel R, Bettmann M, Schaffarczyk R, Linscheid M, Hetzer R, Ewert R.
    Eur Heart J; 2003 Feb 11; 24(4):356-65. PubMed ID: 12581683
    [Abstract] [Full Text] [Related]

  • 5. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
    Saji T, Ozawa Y, Nakayama T, Matsuura H, Hashiguchi R, Matsuo N, Muto H, Yamazaki J, Morishita T, Saito T.
    J Cardiol; 1996 Apr 11; 27(4):197-205. PubMed ID: 8642506
    [Abstract] [Full Text] [Related]

  • 6. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.
    Schermuly RT, Kreisselmeier KP, Ghofrani HA, Samidurai A, Pullamsetti S, Weissmann N, Schudt C, Ermert L, Seeger W, Grimminger F.
    Circ Res; 2004 Apr 30; 94(8):1101-8. PubMed ID: 15031263
    [Abstract] [Full Text] [Related]

  • 7. Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension.
    Krowka MJ, Frantz RP, McGoon MD, Severson C, Plevak DJ, Wiesner RH.
    Hepatology; 1999 Sep 30; 30(3):641-8. PubMed ID: 10462369
    [Abstract] [Full Text] [Related]

  • 8. Prostanoid therapy for pulmonary arterial hypertension.
    Badesch DB, McLaughlin VV, Delcroix M, Vizza CD, Olschewski H, Sitbon O, Barst RJ.
    J Am Coll Cardiol; 2004 Jun 16; 43(12 Suppl S):56S-61S. PubMed ID: 15194179
    [Abstract] [Full Text] [Related]

  • 9. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
    Kieler-Jensen N, Lundin S, Ricksten SE.
    J Heart Lung Transplant; 1995 Jun 16; 14(3):436-43. PubMed ID: 7654728
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Peri-operative pulmonary hypertension in paediatric patients: current strategies in children with congenital heart disease.
    Gorenflo M, Gu H, Xu Z.
    Cardiology; 2010 Jun 16; 116(1):10-7. PubMed ID: 20424447
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis.
    Menon N, McAlpine L, Peacock AJ, Madhok R.
    Arthritis Rheum; 1998 Mar 16; 41(3):466-9. PubMed ID: 9506575
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.